Website News and Research

RSS

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

An interview with Kitty van Weezenbeek, Director of Surveillance, Prevention and Control of AMR for the World Health Organistion (WHO) AMR division.

20 Nov 2023

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and elexacaftor) and Kalydeco (ivacaftor) for children aged two to five years old.

20 Nov 2023

New study provides comprehensive picture of perioperative cardiac arrest in the UK

A new study ‒ that has examined all cardiac arrests occurring during or soon after surgery in more than 300 UK hospitals over a one-year period ‒ has identified that this extremely dangerous and often fatal event occurs in 3 per 10,000 surgeries requiring anesthesia.

16 Nov 2023

Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood

An interview with Dr Beverley Isherwood.

16 Nov 2023

New research explores the unique effects of ADHD medications on Drosophila brain cells

The effect of two drugs used for the treatment of attention-deficit/hyperactivity disorder.

15 Nov 2023

New app aims to ease burden on caregivers of dementia patients

With the number of Americans living with dementia expected to more than double to 13.8 million by 2060, two Regenstrief Institute research scientists and Indiana University professors have created an app to ease the burden on caregivers.

14 Nov 2023

Young people begin to use nicotine through vaping rather than through cigarettes

Young adults are now more likely to vape than to use traditional cigarettes. After years of public health success in decreasing the numbers of people using cigarettes, researchers are seeing striking increases in the numbers of young people who use e-cigarettes regularly – so much so that, for the first time, there are more young people who begin to use nicotine through vaping rather than through cigarettes.

13 Nov 2023

Fertility Mapper launches groundbreaking NHS Fertility Funding Calculator

Fertility Mapper, the review platform for fertility clinics powered by community data publishes a brand new UK wide report today The True Cost of Fertility using transparency as a catalyst for awareness and understanding of the true cost of fertility.

13 Nov 2023

UK regulator approves a diabetes drug for weight management in obese and overweight patients

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (8 November 2023) authorised via a national application route, a new indication for the diabetes medicine, Mounjaro (tirzepatide), for weight loss and weight management in adults aged 18 and over.

13 Nov 2023

US to cover HIV prevention drugs for older Americans to stem spread of the virus

A proposed federal policy aims to protect older Americans from contracting HIV by offering free preventive medication, the latest effort to catch up to much of Europe and Africa in stemming the spread of the virus.

8 Nov 2023

Three new studies show low-dose atropine can help slow myopia in children

Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050.

6 Nov 2023

Study reveals significant deficit in the UK's prosthetic and orthotic workforce

A Staffordshire University study has revealed a significant deficit in the number of prosthetists, orthotists, prosthetic and orthotic technicians, and support workers in the UK.

6 Nov 2023

Analysis finds implicit bias of healthcare professionals towards transgender people

By analyzing data from the Harvard Implicit Association Test - a widely accepted measure of a person's attitudes toward people based on characteristics like race, gender, and sexuality - researchers find that healthcare professionals, and in particular nurses, are more biased against transgender people than are people who are not healthcare professionals.

3 Nov 2023

AZoNetwork launches AZoAI, an open - access platform for the artificial intelligence industry

Leading scientific publisher introduces its 12th subject-specific website, AZoAI.com - the A to Z of Artificial Intelligence. The website educates and informs how the application of artificial intelligence will impact the science, engineering and healthcare sectors and provides industry experts in these fields with the latest news and content from the AI and machine learning industries.

3 Nov 2023

‘Worse than people can imagine’: Medicaid ‘unwinding’ breeds chaos in states

More than two dozen people lined up outside a state public assistance office in Montana before it opened to ensure they didn't get cut off from Medicaid.

2 Nov 2023

Science, Innovation, and Xenotransplantation: A Discussion with Dr. Wenning Qin

In this interview, we delve deep into the pioneering world of xenotransplantation and the evolving landscape of gene editing.

2 Nov 2023

Repurposing of DFMO could lead to innovative therapies for type 1 diabetes

A recent study led by Indiana University School of Medicine in collaboration with the University of Chicago Medicine presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency.

1 Nov 2023

Gubernatorial candidates quarrel over glory for winning opioid settlements

Opioid settlement cash is not inherently political. It's not the result of a law passed by Congress nor an edit to the state budget. It's not taxpayer money. Rather, it's coming from health care companies that were sued for fueling the opioid crisis with prescription painkillers.

1 Nov 2023

Trastuzumab deruxtecan offers added benefit for patients with HER2-low breast cancer

The antibody-drug conjugate trastuzumab deruxtecan is approved for various therapeutic indications. Since March 2023, it can also be used as monotherapy for the treatment of adults with unresectable or metastatic HER2-low breast cancer who have received prior chemotherapy at this disease stage or developed disease recurrence early after adjuvant chemotherapy.

31 Oct 2023

Start shopping: Enrollment begins Nov. 1 for most Obamacare insurance plans

For millions of Americans who buy their own health insurance through the Affordable Care Act marketplace, the end of the year brings a day of reckoning: It's time to compare benefits and prices and change to a new plan or enroll for the first time.

31 Oct 2023

Website News and Research

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

New study provides comprehensive picture of perioperative cardiac arrest in the UK

Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood

New research explores the unique effects of ADHD medications on Drosophila brain cells

New app aims to ease burden on caregivers of dementia patients

Young people begin to use nicotine through vaping rather than through cigarettes

Fertility Mapper launches groundbreaking NHS Fertility Funding Calculator

UK regulator approves a diabetes drug for weight management in obese and overweight patients

US to cover HIV prevention drugs for older Americans to stem spread of the virus

Three new studies show low-dose atropine can help slow myopia in children

Study reveals significant deficit in the UK's prosthetic and orthotic workforce

Analysis finds implicit bias of healthcare professionals towards transgender people

AZoNetwork launches AZoAI, an open - access platform for the artificial intelligence industry

‘Worse than people can imagine’: Medicaid ‘unwinding’ breeds chaos in states

Science, Innovation, and Xenotransplantation: A Discussion with Dr. Wenning Qin

Repurposing of DFMO could lead to innovative therapies for type 1 diabetes

Gubernatorial candidates quarrel over glory for winning opioid settlements

Trastuzumab deruxtecan offers added benefit for patients with HER2-low breast cancer

Start shopping: Enrollment begins Nov. 1 for most Obamacare insurance plans

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News